Galmed Pharmaceuticals Ltd. EOCN
3.63
0.01
0.28%
as of 25 Sep
- Market cap
- $3.8M
- P/E
- 0.0×
Follow EOCN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
3.29 | 3.97 | 4.04 | 4.92 | |
Current Ratio |
4.16 | 7.71 | 6.55 | 7.98 | |
Net Debt/EBITDA |
3.20 | 3.84 | 3.65 | 5.56 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.78 | 1.33 | 0.40 | 1.02 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.35 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.23) | (3.08) | (3.61) | (2.84) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(2.23) | (3.08) | (3.61) | (2.84) | |
Cash per Share |
9.37 | 9.47 | 20.66 | 17.02 | |
Shareholders Equity per Share |
13.38 | 16.93 | 29.29 | 28.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
13.38 | 16.93 | 29.29 | 28.00 | |
Free Cash Flow |
(2.13) | (2.54) | (1.94) | (1.93) | |
Working Capital |
8.90 | 13.95 | 15.78 | 17.25 | |
Net Current Asset Value |
6.17 | 13.95 | 15.78 | 17.25 | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.38 | 0.45 | 0.51 | 0.49 | |
Average Payables |
1.63 | 1.52 | 1.66 | 1.51 | |
Average Assets |
20.61 | 17.36 | 18.56 | 21.27 | |
Average Common Equity |
16.63 | 15.41 | 16.05 | 18.77 |
Columns are period end dates